Etiology, clinical outcome, and laboratory features in children with neutropenia: Analysis of 104 cases
Etiology, clinical outcome, and laboratory features in children with neutropenia: Analysis of 104 cases
复制标题
DOI：
10.1111/pai.12177
复制
发表时间：
2014-05-01
影响因子：
4.4
通讯作者：
Finocchi, Andrea
中科院分区：
文献类型：
--
作者：
Angelino, Giulia;Caruso, Roberta;Finocchi, Andrea
BackgroundNeutropenia is not uncommon in childhood. The aim of our study was to analyze the underlying causes of neutropenia and to evaluate its clinical significance in a series of children referred to our center.MethodsOne hundred and four consecutive children with neutropenia were enrolled in this study. Clinical and laboratory features were analyzed.ResultsThe majority of patients (63.5%) showed chronic neutropenia. Among all chronic forms, the most frequent was chronic idiopathic neutropenia (CIN), followed by autoimmune neutropenia (AIN). Congenital neutropenia was identified in 6 patients. Acute neutropenia was mainly due to infections. Overall, at the time of first detection, neutropenia was more frequently severe or moderate. One-third of our patients who presented with severe neutropenia were ultimately diagnosed with a post-infectious acute form. Conversely, nearly half patients with CIN, AIN, or congenital neutropenia showed moderate/mild neutropenia at onset. Among patients with AIN and CIN, nearly half recovered between 7months and 46months and approximately one-fourth experienced infectious episodes during follow-up. No significant difference was noticed in terms of mean ANC between patients with and without remission, neither between patients with and without infections.ConclusionsOur study confirms the great etiological heterogeneity of neutropenia in children. We could not demonstrate a correlation between ANC level at onset and the underlying disorder, nor a correlation between mean ANC and duration of neutropenia or infectious episodes during follow-up. Neutropenia remains a disease of concern to pediatricians, requiring several laboratory investigations, prolonged follow-up, and, in few cases, advanced molecular methods.
